دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Andrew N. Antoszyk, MD1; Adam R. Glassman, MS2; Wesley T. Beaulieu, PhD2; Lee M. Jampol, MD3; Chirag D. Jhaveri, MD4,5; Omar S. Punjabi, MD1; Hani Salehi-Had, MD6; John A. Wells III, MD7; Maureen G. Maguire, PhD8; Cynthia R. Stockdale, MSPH2; Daniel F. Martin, MD9; Jennifer K. Sun, MD, MPH10; for the DRCR Retina Network
doi : 10.1001/jama.2020.23027
JAMA. 2020;324(23):2383-2395
Vitreous hemorrhage from proliferative diabetic retinopathy can cause loss of vision. The best management approach is unknown.
Association Between Depressive Symptoms and Incident Cardiovascular Diseases
Eric L. Harshfield, PhD1,2; Lisa Pennells, PhD1; Joseph E. Schwartz, PhD3,4; Peter Willeit, MD1,5; Stephen Kaptoge, PhD1; Steven Bell, PhD1,2; Jonathan A. Shaffer, PhD6; Thomas Bolton, MSc1; Sarah Spackman, MMath1; Sylvia Wassertheil-Smoller, PhD7; Frank Kee, MD8; Philippe Amouyel, MD9; Steven J. Shea, MD10; Lewis H. Kuller, PhD11; Jussi Kauhanen, MD12; E. M. van Zutphen, PhD13,14,15; Dan G. Blazer, MD16; Harlan Krumholz, MD17; Paul J. Nietert, PhD18; Daan Kromhout, MD19; Gail Laughlin, PhD20; Lisa Berkman, PhD21; Robert B. Wallace, MD22; Leon A. Simons, MD23; Elaine M. Dennison, PhD24; Elizabeth L. M. Barr, PhD25; Haakon E. Meyer, MD26; Angela M. Wood, PhD1; John Danesh, FMedSci1; Emanuele Di Angelantonio, MD, PhD1; Karina W. Davidson, PhD27; for the Emerging Risk Factors Collaboration
doi : 10.1001/jama.2020.23068
JAMA. 2020;324(23):2396-2405
It is uncertain whether depressive symptoms are independently associated with subsequent risk of cardiovascular diseases (CVDs).
Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease
Maneesh Sud, MD1,2,3,4; Lu Han, PhD3; Maria Koh, MSc3; Peter C. Austin, PhD2,3; Michael E. Farkouh, MD, MSc4,5; Hung Q. Ly, MD6; Mina Madan, MD, MHS1,4; Madhu K. Natarajan, MD, MSc7; Derek Y. So, MD, MSc8; Harindra C. Wijeysundera, MD, PhD1,2,3,4; Jiming Fang, PhD3; Dennis T. Ko, MD, MSc1,2,3,4
doi : 10.1001/jama.2020.22708
JAMA. 2020;324(23):2406-2414
Fractional flow reserve (FFR) is an invasive measurement used to assess the potential of a coronary stenosis to induce myocardial ischemia and guide decisions for percutaneous coronary intervention (PCI). It is not known whether established FFR thresholds for PCI are adhered to in routine interventional practice and whether adherence to these thresholds is associated with better clinical outcomes.
Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic
Haiden A. Huskamp, PhD1; Alisa B. Busch, MD, MS2; Lori Uscher-Pines, PhD3; Michael L. Barnett, MD, MS4; Lauren Riedel, MPH1; Ateev Mehrotra, MD, MPH1
doi : 10.1001/jama.2020.21512
JAMA. 2020;324(23):2440-2442
no abstract
Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic
Jessica Duncan Cance, MPH, PhD1; Erin Doyle, MS2
doi : 10.1001/jama.2020.22154
JAMA. 2020;324(23):2442-2444
no abstract
Screening for Hepatitis B Virus Infection in Adolescents and Adults
US Preventive Services Task Force
doi : 10.1001/jama.2020.22980
JAMA. 2020;324(23):2415-2422
An estimated 862?000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and parts of South America, often become infected at birth and account for up to 95% of newly reported chronic infections in the US. Other high-prevalence populations include persons who inject drugs; men who have sex with men; persons with HIV infection; and sex partners, needle-sharing contacts, and household contacts of persons with chronic HBV infection. Up to 60% of HBV-infected persons are unaware of their infection, and many remain asymptomatic until onset of cirrhosis or end-stage liver disease.
Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults
Roger Chou, MD1,2; Ian Blazina, MPH1; Christina Bougatsos, MPH1; Rebecca Holmes, MD, MS1; Shelley Selph, MD, MPH1,3; Sara Grusing, BA1; Janice Jou, MD, MHS1,4
doi : 10.1001/jama.2020.19750
JAMA. 2020;324(23):2423-2436
A 2014 review for the US Preventive Services Task Force (USPSTF) found antiviral therapy for hepatitis B virus (HBV) infection associated with improved intermediate outcomes, although evidence on clinical outcomes was limited.
Patient Consumerism, Healing Relationships, and Rebuilding Trust in Health Care
Dhruv Khullar, MD, MPP1,2; Gwen Darien, BA3; Debra L. Ness, MS4
doi : 10.1001/jama.2020.12938
JAMA. 2020;324(23):2359-2360
Rebuilding Trust and Relationships in Medical Centers
Reshma Gupta, MD, MSHPM1,2; Leah Binder, MA, MGA3; Christopher Moriates, MD1,4
doi : 10.1001/jama.2020.14933
JAMA. 2020;324(23):2361-2362
The Enduring Importance of Trust in the Leadership of Health Care Organizations
Sachin H. Jain, MD, MBA1; Catherine Lucey, MD2; Francis J. Crosson, MD3
doi : 10.1001/jama.2020.18555
JAMA. 2020;324(23):2363-2364
Transparency as a Trust-Building Practice in Physician Relationships With Patients
Tara Montgomery, BA1; Jeffrey S. Berns, MD2; Clarence H. Braddock III, MD, MPH3
doi : 10.1001/jama.2020.18368
JAMA. 2020;324(23):2365-2366
Addressing Medical Misinformation in the Patient-Clinician Relationship
Vineet M. Arora, MD, MAPP1; Sonia Madison, MS2; Lisa Simpson, MD, MPH3
doi : 10.1001/jama.2020.4263
JAMA. 2020;324(23):2367-2368
Human-Centered Design and Trust in Medicine
Alyse Wheelock, MD1; Christine Bechtel, MA2; Bruce Leff, MD3
doi : 10.1001/jama.2020.21080
JAMA. 2020;324(23):2369-2370
Trust in Health Care in the Time of COVID-19
David W. Baker, MD, MPH1
doi : 10.1001/jama.2020.23343
JAMA. 2020;324(23):2373-2375
Anti-VEGF Therapy or Vitrectomy Surgery for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Gavin Siew-Wei Tan, MD, PhD1,2; Usha Chakravarthy, MD, PhD3; Tien Yin Wong, MD, PhD1,2
doi : 10.1001/jama.2020.22829
JAMA. 2020;324(23):2375-2377
Physiology-Based Revascularization Decisions and Improved Clinical Outcomes Following Percutaneous Coronary Interventions
Richard G. Bach, MD1
doi : 10.1001/jama.2020.22998
JAMA. 2020;324(23):2377-2380
USPSTF 2020 Hepatitis B Screening Recommendation
Jessica P. Hwang, MD, MPH1; Anna S. Lok, MD2
doi : 10.1001/jama.2020.18831
JAMA. 2020;324(23):2380-2382
Trijardy XR—A New 3-Drug Combination for Type 2 Diabetes
doi : 10.1001/jama.2020.10406
JAMA. 2020;324(23):2437-2438
JAMA Network Articles of the Year 2020
Jennifer Abbasi
doi : 10.1001/jama.2020.22443
JAMA. 2020;324(23):2350-2353
Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More
doi : 10.1001/jama.2020.24075
JAMA. 2020;324(23):2354-2355
Quality Issues Prompt Guidelines for Compounded Drug Pharmacies
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.24226
JAMA. 2020;324(23):2357
Sesame Should Be on Food Labels to Warn Consumers With Allergy
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.23797
JAMA. 2020;324(23):2357
Device Approved for Adults With Nightmare Disorder
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.24228
JAMA. 2020;324(23):2357
Urgent Action Needed to Prevent Measles, Polio Resurgence
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.23615
JAMA. 2020;324(23):2356
Creating More Climate-Proof Health Care Facilities
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.24250
JAMA. 2020;324(23):2356
Global Regulators Set Standards for Safe Vaccines
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.24252
JAMA. 2020;324(23):2356
Home From the Hospital
Shane O’Hanlon, MB, MSc1
doi : 10.1001/jama.2020.17691
JAMA. 2020;324(23):2447
Screening for Hepatitis B in Nonpregnant Adolescents and Adults
Jill Jin, MD, MPH1
doi : 10.1001/jama.2020.23519
JAMA. 2020;324(23):2452
Conversational Agents in Health Care
Alison Darcy, PhD1; Athena Robinson, PhD1; Paul Wicks, PhD1
doi : 10.1001/jama.2020.21509
JAMA. 2020;324(23):2444
Conversational Agents in Health Care—Reply
John D. McGreevey III, MD1; C. William Hanson III, MD1; Ross Koppel, PhD2
doi : 10.1001/jama.2020.21518
JAMA. 2020;324(23):2444-2445
Exome Sequencing as Part of a Multidisciplinary Approach to Diagnosis
Alice Doreille, MD1; Laure Raymond, MD2; Laurent Mesnard, MD, PhD1
doi : 10.1001/jama.2020.21506
JAMA. 2020;324(23):2445
Exome Sequencing as Part of a Multidisciplinary Approach to Diagnosis—Reply
Jan M. Friedman, MD, PhD1; Kenneth Lyons Jones, MD2; John C. Carey, MD, MPH3
doi : 10.1001/jama.2020.21521
JAMA. 2020;324(23):2445-2446
